Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IL-1 can act as number one.

Ana M Gamero1, Joost J Oppenheim

  • 1Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, FCRF, Frederick, Maryland 21702, USA.

Immunity
|January 18, 2006
PubMed
Summary

Interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) use the same adapter molecule, MyD88. However, IL-1R is crucial for skin infection defense, while TLR2 is not.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conditional Stat2 Knockout Mice as a Platform for Modeling Human Diseases.

Immuno·2026
Same author

STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling.

Current oncology (Toronto, Ont.)·2025
Same author

LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells.

Frontiers in immunology·2024
Same author

Development of a novel modified vaccine (TheraVac<sup>M</sup>) for curative treatment of mouse solid tumors.

Cytokine·2023
Same author

Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies.

Cancers·2023
Same author

A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis.

Theranostics·2023

Area of Science:

  • Immunology
  • Microbiology
  • Cellular Signaling

Background:

  • Interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) are key pattern recognition receptors involved in innate immunity.
  • Both IL-1R and TLR2 signal through the shared adapter molecule MyD88, suggesting potentially overlapping functions.
  • Understanding the distinct roles of these receptors is critical for developing targeted immunotherapies.

Discussion:

  • Despite sharing the MyD88 adapter, IL-1R and TLR2 signaling pathways diverge downstream.
  • This divergence leads to differential requirements for host defense against specific pathogens.
  • The study highlights the complexity of innate immune signaling networks.

Key Insights:

  • Interleukin-1 receptor signaling is essential for effective host defense against cutaneous infection challenges.
  • Toll-like receptor 2 signaling is not essential for this specific host defense mechanism.
  • Distinct downstream signaling events dictate the functional outcomes of IL-1R and TLR2 activation.

Outlook:

  • Further research into the specific downstream molecules differentiating IL-1R and TLR2 function is warranted.
  • This knowledge can inform the development of novel therapeutic strategies targeting specific immune pathways.
  • Investigating other TLRs and their roles in conjunction with IL-1R in various infection models is a future direction.

Related Experiment Videos